....YoY revenue growth is +65%.
I will post a trailing 12 month track of revenues on future Appendices (2Q21-1Q22 = $1,375K vs $835K for previous corresponding period [pcp]).
2 big data announcements this quarter to come are the more likely candidates for share price movement, though I was/am hoping for three, with hopefully some initial data on the ATI vs surgery RCT in tennis elbow, on full recruitment.
Ann: Appendix 4C - Quarterly, page-4
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.0¢ |
Change
-0.025(3.65%) |
Mkt cap ! $156.6M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.5¢ | $181.8K | 274.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 32772 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 5130 | 2 |
View Market Depth
| Last trade - 14.27pm 13/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |